Park Kyung-Ah, Min Ju-Hong, Oh Sei Yeul, Kim Byoung Joon
Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Ilwon-dong, Kangnam-gu, Seoul, South Korea.
Jpn J Ophthalmol. 2019 Jul;63(4):337-343. doi: 10.1007/s10384-019-00666-7. Epub 2019 Apr 20.
To present cases with idiopathic third and sixth cranial nerve neuritis.
Retrospective observational study METHODS: The results of high resolution pre- and post- cranial nerve magnetic resonance images (MRI) with three-dimensional sequences for visualizing cranial nerves in patients with third, fourth, and sixth cranial nerve palsies who were treated at the Neuro-ophthalmology Department of Samsung Medical Center were reviewed. Patients with cranial nerve enhancement confirmed by experienced radiologists were identified. The medical records of these patients were reviewed, and their demographics, clinical presentations, laboratory results, and clinical outcomes were analyzed.
Of 265 patients with third, fourth, and sixth cranial nerve palsy, 60 were identified by high resolution MRI as having enhancement of the corresponding cranial nerve. Among these, 17 patients with infiltrative, granulomatous, or tumorous lesions were excluded. In addition, 28 patients with identifiable causes of cranial nerve palsy, such as Miller-fisher syndrome, virus infection, or radiation-induced neuropathy, as well as patients with vasculopathic risk factors, were also excluded. Ultimately, a total of 15 patients with idiopathic third and sixth cranial nerve neuritis were included in this study. The mean age of these patients was 43 ± 15 years. Eight patients had sixth cranial nerve palsy, six third cranial nerve palsy (two partial and four complete), and one patient with complete third and sixth cranial nerve palsy. Nine patients received steroid treatment. Eleven patients recovered fully within a period ranging from a few days to one year. Two patients were much improved up to 1 month after initial presentation, but were then ultimately lost to follow-up. Another patient was lost to follow-up after the initial work-up. The other patient lost to follow-up had partially recovered during the first 6 months.
We present patients with idiopathic third and sixth cranial nerve neuritis. They tended to respond well to steroid treatment and to have good prognoses. In order to better understand the long-term prognosis of cranial nerve neuritis and possible association with other neurologic disorders, a larger scale and longer-term study is needed.
介绍特发性动眼神经和展神经神经炎病例。
回顾性观察研究
回顾了三星医疗中心神经眼科治疗的动眼神经、滑车神经和展神经麻痹患者的高分辨率颅神经磁共振成像(MRI)前后结果,采用三维序列来显示颅神经。确定了经经验丰富的放射科医生确认有颅神经强化的患者。查阅了这些患者的病历,并分析了他们的人口统计学、临床表现、实验室检查结果和临床结局。
在265例动眼神经、滑车神经和展神经麻痹患者中,60例经高分辨率MRI确定相应颅神经有强化。其中,17例有浸润性、肉芽肿性或肿瘤性病变的患者被排除。此外,28例有可识别的颅神经麻痹病因的患者,如米勒-费希尔综合征、病毒感染或放射性神经病,以及有血管病变危险因素的患者也被排除。最终,本研究共纳入15例特发性动眼神经和展神经神经炎患者。这些患者的平均年龄为43±15岁。8例为展神经麻痹,6例为动眼神经麻痹(2例部分性和4例完全性),1例为动眼神经和展神经完全麻痹。9例患者接受了类固醇治疗。11例患者在几天至一年的时间内完全康复。2例患者在初次就诊后1个月内有明显改善,但最终失访。另1例患者在初次检查后失访。另1例失访患者在最初6个月内部分恢复。
我们介绍了特发性动眼神经和展神经神经炎患者。他们往往对类固醇治疗反应良好,预后较好。为了更好地了解颅神经神经炎的长期预后以及与其他神经系统疾病的可能关联,需要进行更大规模和更长期的研究。